Forty Seven Inc.
1490 O' Brien Drive Suite A
1 article with Forty Seven Inc.
Forty Seven Receives $5M Grant From The CIRM to Support Ongoing Clinical Trial in Acute Myeloid Leukemia
- CIRM grant will support further development of Forty Seven Inc.'s CD47 antibody Hu5F9-G4 in an ongoing second trial for the treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome - [06-December-2017] MENLO PARK, Calif., Dec. 6, 2017 /PRNewswire/ -- Forty Seven Inc., a clinical-stage company focused on developing the next generation of transformati